FIBROBLAST GROWTH FACTOR; FGF2

This assay serves as an independent prognostic indicator for patients with Chronic Myeloid Leukemia (CML), Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma.

  • Test Type:
  • Pre-test Information:
    No special preparation required
  • Report Delivery:
    Sample by 7th of the month; Report after 2–3 weeks
  • Components:
    0

Sample Report